|1.||Ahmed, Farhan: 1 article (01/2013)|
|2.||Golla, Kishore: 1 article (01/2013)|
|3.||Bhaskar, Cherukuvada: 1 article (01/2013)|
|4.||Kondapi, Anand K: 1 article (01/2013)|
|5.||Hirsch, E C: 1 article (12/2009)|
|6.||Sabeti, P: 1 article (04/2009)|
|7.||Chowdhury, F: 1 article (04/2009)|
|8.||Harris, J B: 1 article (04/2009)|
|9.||Qadri, F: 1 article (04/2009)|
|10.||Lebrun, L M: 1 article (04/2009)|
11/01/1992 - "In conclusion, since the lactotransferrin receptor expression was not enhanced at the surface of cancerous cell lines and was not altered by the oncogene transformation of a normal cell (HBL100) to a tumorigenic cell (HH9), the lactotransferrin receptor cannot be considered as a marker of tumor progression."
01/01/2013 - "Since apotransferrin and lactoferrin receptors are highly expressed on the surface of metabolically active cancer cells, the principal objective of present study is to evaluate efficacy of doxorubicin loaded apotransferrin and lactoferrin nanoparticles (apodoxonano or lactodoxonano) in oral treatment of HCC in rats. "
|2.||Parkinson Disease (Parkinson's Disease)
10/10/1995 - "Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease."
10/10/1995 - "These data suggest that lactoferrin receptors on vulnerable neurons may increase intraneuronal iron levels and contribute to the degeneration of nigral dopaminergic neurons in Parkinson disease."
12/01/2009 - "In previous studies we excluded a role of transferrin and its receptor in iron accumulation while we showed that lactoferrin receptors were overexpressed in blood vessels and dopaminergic neurons in Parkinson's disease. "
09/01/1997 - "Iron deposition in the substantia nigra in Parkinson's disease has been associated with an increase in lactoferrin receptors and a reduction in ferritin concentration. "
10/10/1995 - "To investigate whether neuronal death in Parkinson disease may be associated with changes in a pathway supplementary to that of transferrin, lactoferrin (lactotransferrin) receptor expression was studied in the mesencephalon. "
11/01/1992 - "The aim of this study was to investigate the presence of lactotransferrin receptor on breast non-malignant SV-40 immortalized cells (HBL100 and NB54T), benign mastopathy immortalized cells (NPM14T and NPM21T1), hst oncogene transformed HBL100 cell line (tumorigenic HH9 cells) and breast carcinoma cells (T47D, MCF7, VHB1, BT20 and MDA-MB 231). "
11/01/1992 - "Characterization of lactotransferrin receptor in epithelial cell lines from non-malignant human breast, benign mastopathies and breast carcinomas."
06/01/1995 - "Effect of intracellular iron depletion by picolinic acid on expression of the lactoferrin receptor in the human colon carcinoma cell subclone HT29-18-C1."
|5.||Cystic Fibrosis (Mucoviscidosis)
04/01/2009 - "In a family-based study of 76 pedigrees from Dhaka, Bangladesh, we evaluated the association between cholera and five candidate genes-the cystic fibrosis transmembrane receptor; lactoferrin; long palate, lung and nasal epithelium clone 1 (LPLUNC1); estrogen-related receptor alpha and calcium-activated chloride channel 1. We found a significant association with a marker in the promoter region of LPLUNC1 (rs11906665), a member of a family of evolutionarily conserved innate immunity proteins. "
|4.||Transferrin (beta 2 Transferrin)
|5.||Proteins (Proteins, Gene)
|7.||Chloride Channels (Chloride Channel)
|9.||ERRalpha estrogen-related receptor
|10.||Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)